Business / Finance

RSS
Owlstone Medical secures $6.5 million to support development of breath-based diagnostics for infectious disease

Owlstone Medical secures $6.5 million to support development of breath-based diagnostics for infectious disease

Everything you need to know about next generation sequencing in INTEGRA Biosciences’ eBook

Everything you need to know about next generation sequencing in INTEGRA Biosciences’ eBook

Bio-Rad announces collaboration agreement with oncocyte to commercialize transplant monitoring with droplet digital PCR

Bio-Rad announces collaboration agreement with oncocyte to commercialize transplant monitoring with droplet digital PCR

Teva UK and Closed Loop Medicine announce strategic partnership to advance development of personalised medicines

Teva UK and Closed Loop Medicine announce strategic partnership to advance development of personalised medicines

Key Charpentier/Doudna CRISPR patent upheld by China National Intellectual Property Administration

Key Charpentier/Doudna CRISPR patent upheld by China National Intellectual Property Administration

Ubiquigent and Debiopharm enter agreement to support USP1 inhibitor programme for Debio 0432

Ubiquigent and Debiopharm enter agreement to support USP1 inhibitor programme for Debio 0432

Bio-Rad launches validated antibodies for rare cell and circulating tumor cell enumeration

Bio-Rad launches validated antibodies for rare cell and circulating tumor cell enumeration

Nuclera joins Tech Nation’s Future Fifty program

Nuclera joins Tech Nation’s Future Fifty program

Arrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapies

Arrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapies

Logical Biological recognized as one of ‘Europe's fastest-growing companies’ due to customer centric approach and quality commitment

Logical Biological recognized as one of ‘Europe's fastest-growing companies’ due to customer centric approach and quality commitment

Nuclera appoints Joseph Bertelsen as Chief Commercial Officer

Nuclera appoints Joseph Bertelsen as Chief Commercial Officer

World Vaccine Congress draws leaders from government, science and industry

World Vaccine Congress draws leaders from government, science and industry

Exploristics and Exonate announce successful collaboration to enhance clinical trial study design using cloud-based simulation

Exploristics and Exonate announce successful collaboration to enhance clinical trial study design using cloud-based simulation

Metrion Biosciences strengthens team with three key appointments

Metrion Biosciences strengthens team with three key appointments

Ubiquigent enters agreement with Astellas subsidiary, Nanna Therapeutics

Ubiquigent enters agreement with Astellas subsidiary, Nanna Therapeutics

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.